ETF · holdings as filed 2026-04-30
What's inside IDNA?
iShares Genomics Immunology and Healthcare ETF
- Holdings
- 62
- positions in the fund
- Top 10
- 53%
- of fund assets
- Expense ratio
- 0.47%
- net, per year
- Fund size
- $160M
- total net assets
Top 20 holdings
| Rank | Logo | Ticker / Name | Weight | |
|---|---|---|---|---|
| 1 | B  | BISXXBCF INSTITUTIONAL-SL AGNCY | 17.45% | |
| 2 | R  | RVMDREVOLUTION MEDICINES INC | 5.70% | |
| 3 | M  | MRNAMODERNA INC | 5.22% | |
| 4 | I  | IPSEFIPSEN | 4.36% | |
| 5 | B  | BAYZFBAYER AG-REG | 3.64% | |
| 6 | T  | TKPHFTAKEDA PHARMACEUTICAL CO LTD | 3.51% | |
| 7 | M  | MRKMERCK & CO. INC. | 3.45% | |
| 8 | G  | GLAXFGSK PLC | 3.43% | |
| 9 | B  | BNTXBIONTECH SE-ADR | 3.39% | |
| 10 | R  | RHHVFROCHE HOLDING AG | 3.32% | |
| 11 | E  | EXELEXELIXIS INC | 3.16% | |
| 12 | T  | TWSTTWIST BIOSCIENCE CORP | 3.15% | |
| 13 | R  | REGNREGENERON PHARMACEUTICALS | 3.10% | |
| 14 | S  | SNYNFSANOFI | 2.98% | |
| 15 | V  | VRTXVERTEX PHARMACEUTICALS INC | 2.96% | |
| 16 | I  | INCYINCYTE CORP | 2.93% | |
| 17 | G  | GNMSFGENMAB A/S | 2.63% | |
| 18 | I  | IDYAIDEAYA BIOSCIENCES INC | 2.25% | |
| 19 | I  | IBRXIMMUNITYBIO INC | 2.17% | |
| 20 | C  | CAICARIS LIFE SCIENCES INC | 2.03% |
Top holdings — Health Care
Your 10 largest positions in this sector
1
R
RVMDREVOLUTION MEDICINES INC
5.70%2
M
MRNAMODERNA INC
5.22%3
T
TKPHFTAKEDA PHARMACEUTICAL CO LTD
3.51%4
M
MRKMERCK & CO. INC.
3.45%5
G
GLAXFGSK PLC
3.43%6
B
BNTXBIONTECH SE-ADR
3.39%7
E
EXELEXELIXIS INC
3.16%8
T
TWSTTWIST BIOSCIENCE CORP
3.15%9
R
REGNREGENERON PHARMACEUTICALS
3.10%10
S
SNYNFSANOFI
2.98%Top holdings — United States
Your 10 largest positions in this country
1
B
BISXXBCF INSTITUTIONAL-SL AGNCY
17.45%2
R
RVMDREVOLUTION MEDICINES INC
5.70%3
M
MRNAMODERNA INC
5.22%4
M
MRKMERCK & CO. INC.
3.45%5
E
EXELEXELIXIS INC
3.16%6
T
TWSTTWIST BIOSCIENCE CORP
3.15%7
R
REGNREGENERON PHARMACEUTICALS
3.10%8
V
VRTXVERTEX PHARMACEUTICALS INC
2.96%9
I
INCYINCYTE CORP
2.93%10
I
IDYAIDEAYA BIOSCIENCES INC
2.25%Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold IDNA alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Funds similar to IDNA
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.
Informational and educational only — not investment advice.